AIDX

News

globenewswire.com20/20 Biolabs' Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefightersglobenewswire.comMay 27

globenewswire.com20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demandglobenewswire.comMay 22

globenewswire.com20/20 BioLabs Reports First Quarter 2026 Financial Results and Recent Operational Progressglobenewswire.comMay 20

globenewswire.com20/20 BioLabs to Attend Sidoti Micro-Cap Virtual Conference on May 20, 2026globenewswire.comMay 14

globenewswire.com20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolinaglobenewswire.comMay 12

Trade AIDX

About 20/20 Biolabs, Inc. Common Stock

20/20 GeneSystems, Inc. operates as a specialized clinical diagnostic company, focusing primarily on screening for cancer and analyzing viral infections. The firm offers advanced blood tests for the early detection of various cancers, including a notable product called OneTest. Additionally, it provides services for identifying viruses, such as rapid COVID-19 test kits like the Assure COVID-19 IgG/IgM rapid assay. The company also manages the Clinical Lab Innovation Axcelerator (CLIAx), a collaborative laboratory space designed to help developers of diagnostic products bring their innovations to the U.S. market. Furthermore, 20/20 GeneSystems delivers its cancer screening algorithm technology to healthcare providers via a software-as-a-service (SaaS) platform. It actively supports emerging diagnostic startups by offering them access to shared lab infrastructure and vital resources. Founded in 2000, the company is headquartered in Gaithersburg, Maryland.

CEO: Jonathan Cohen
IPO Date: Jun 15, 2023

Market Data

Open: $0.8272
High: $0.86
Low: $0.79
Volume: 69.9K
52W High: $50.00
52W Low: $0.79

Valuation

Market Cap: $4.5M
Enterprise Value: $868k

Financials

Free Cash Flow: $-1.9B
Revenue: $2.0M
Net Income: $-3.7M
Cash: $1.0B
Debt: $1.3B

Events

EarningsSep 2

EPS est. -0.12